Trial Details
UNKNOWNBasic Information
| Clinical ID | c1461 |
|---|---|
| Identifier | NCT01671956 |
| Trial Title | Evaluation of Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of Bertilimumab in Patients With Active Moderate to Severe Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis, Active Moderate|Ulcerative Colitis, Active Severe |
| Interventions | BIOLOGICAL: Bertilimumab|BIOLOGICAL: Placebo |
Participant Information
| Sponsor | Immune Pharmaceuticals |
|---|---|
| City | Afula |
| Country/Region | Israel |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2025-07-15 |
|---|---|
| Primary Completion Date | 2025-08-18 |
| Completion Date | 2025-03-19 |